TACROLIMUS (WATSON LABORATORIES) Adverse Event: Posterior reversible encephalopathy syndrome
TACROLIMUS (WATSON LABORATORIES) Adverse Event: Posterior reversible encephalopathy syndrome is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TACROLIMUS (WATSON LABORATORIES); Product category: Drug; Primary reaction: Posterior reversible encephalopathy syndrome.
| Primary drug | TACROLIMUS (WATSON LABORATORIES) |
|---|---|
| Product category | Drug |
| Primary reaction | Posterior reversible encephalopathy syndrome |
| All reactions | Posterior reversible encephalopathy syndrome; Cerebral haemorrhage; Subarachnoid haemorrhage |
| Seriousness | Serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Male |
| All drugs reported | TACROLIMUS (WATSON LABORATORIES); PREDNISONE; PREDNISONE; AZATHIOPRINE |
| Reporter country | US |
| Reporter type | 3 |
| Report date | 20140312 |
| Report ID | 10003357 |
$299/mo
Try FDATracker →